Skip to main content
. 2021 Dec 9;10(12):giab080. doi: 10.1093/gigascience/giab080

Figure 5:

Figure 5:

Pan-cancer results summary. Intronic and exonic junctions are given per sample for the NGS-ProToCol, BASIS, and CGGA datasets with their associated clinical parameters. For the colon samples, the predicted CMS classes are provided; for the prostate cancer samples, the Gleason grade and metastatic progression are provided; for the breast cancer samples, the ER, BRCA1, BRCA2, kataegis, and Dr. Disco–detected chr11-hot spot status are provided; and for the glioma samples, the grading, recurrence, IDH1 mutation status, sex, and the Dr. Disco–detected EGFR and chr12 hot spot status are provided.